Shelley B. Thunen
Net Worth

Last updated:

What is Shelley B. Thunen net worth?

The estimated net worth of Ms. Shelley B. Thunen is at least $9,393,063 as of 1 Oct 2024. She owns shares worth $261,810 as insider, has earned $8,540,233 from insider trading and has received compensation worth at least $591,020 in RxSight, Inc..

What is the salary of Shelley B. Thunen?

Ms. Shelley B. Thunen salary is $295,510 per year as Chief Financial Officer & Assistant Sec. in RxSight, Inc..

How old is Shelley B. Thunen?

Ms. Shelley B. Thunen is 71 years old, born in 1954.

What stocks does Shelley B. Thunen currently own?

As insider, Ms. Shelley B. Thunen owns shares in one company:

Company Title Shares Price per share Total value
RxSight, Inc. (RXST) Chief Financial Officer & Assistant Sec. 30,443 $8.6 $261,810

What does RxSight, Inc. do?

RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

RXST logo
RXST
RxSight, Inc.
$8.6

Shelley B. Thunen insider trading

RxSight, Inc.

Ms. Shelley B. Thunen has made 26 insider trades between 2023-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 31,772 units of RXST stock on 26 Jan 2024. As of 1 Oct 2024 she still owns at least 30,443 units of RXST stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 15,000 $16 $240,000
Sale
Common Stock 9,521 $48.69 $463,558
Sale
Common Stock 278 $49.45 $13,747
Option
Stock option (right to buy) 15,000 $16 $240,000
Sale
Common Stock 5,201 $47.96 $249,424
Option
Common Stock 16,505 $4.34 $71,632
Sale
Common Stock 1,803 $59.56 $107,394
Option
Stock Option (right to buy) 10,000 $15.6 $155,980
Sale
Common Stock 8,146 $58.41 $475,783
Sale
Common Stock 1,854 $59.48 $110,270
Option
Common Stock 10,000 $15.6 $155,980
Sale
Common Stock 6,599 $58.55 $386,365
Option
Common Stock 10,247 $15.6 $159,833
Sale
Common Stock 9,620 $52.68 $506,762
Sale
Common Stock 380 $53.04 $20,154
Option
Stock Option (right to buy) 10,000 $15.6 $155,980
Sale
Common Stock 200 $50.37 $10,074
Sale
Common Stock 543 $51.5 $27,965
Sale
Common Stock 662 $50.24 $33,258
Sale
Common Stock 8,938 $49.81 $445,229
Sale
Common Stock 800 $50.27 $40,218
Sale
Common Stock 8,857 $49.82 $441,211
Option
Common Stock 10,000 $15.6 $155,980
Sale
Common Stock 2,473 $57.03 $141,043
Option
Stock Option (right to buy) 10,000 $15.6 $155,980
Sale
Common Stock 1,166 $54.95 $64,066
Sale
Common Stock 6,361 $56.38 $358,620
Option
Stock Option (right to buy) 15,875 $14.95 $237,331
Option
Common Stock 15,875 $14.95 $237,331
Sale
Common Stock 15,875 $47.47 $753,570
Option
Stock Option (right to buy) 6,900 $4.34 $29,946
Option
Common Stock 6,900 $4.34 $29,946
Option
Common Stock 9,125 $14.95 $136,419
Sale
Common Stock 9,125 $47.02 $429,085
Option
Stock Option (right to buy) 9,125 $14.95 $136,419
Option
Common Stock 4,500 $4.34 $19,530
Option
Stock Option (right to buy) 31,772 $15.08 $479,122
Sale
Common Stock 31,772 $47.11 $1,496,715
Option
Stock Option (right to buy) 4,500 $4.34 $19,530
Option
Common Stock 31,772 $15.08 $479,122
Sale
Common Stock 5,481 $39.63 $217,218
Option
Common Stock 10,000 $15.6 $155,980
Option
Stock Option (right to buy) 10,000 $15.6 $155,980
Sale
Common Stock 4,519 $38.77 $175,193
Sale
Common Stock 10,000 $39.32 $393,210
Option
Common Stock 20,000 $15.6 $312,000
Sale
Common Stock 10,000 $39.31 $393,120
Option
Stock Option (right to buy) 20,000 $15.6 $312,000
Sale
Common Stock 20,000 $39.35 $786,980

RxSight key executives

RxSight, Inc. executives and other stock owners filed with the SEC:

  • Dr. Ilya Goldshleger Ph.D. (50) Chief Operating Officer
  • Dr. Ronald M. Kurtz M.D. (62) Pres, Chief Executive Officer & Director
  • Mr. Eric J. Weinberg (64) Chief Commercial Officer
  • Ms. Shelley B. Thunen (71) Chief Financial Officer & Assistant Sec.